Emily Erbelding, M.D., M.P.H.
Director, Division of Microbiology and Infectious Diseases
Emily Erbelding, M.D., M.P.H.
Director, Division of Microbiology and Infectious Diseases
The Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all human infectious agents except HIV. DMID provides funding opportunities and a comprehensive set of resources for researchers that support basic research, preclinical development, and clinical evaluation.
Research Focus
DMID conducts and supports research on nearly 300 infectious agents and investigates the biological properties of these pathogens and the immune system’s responses to them. Findings from this research are vital to NIAID efforts to create vaccines, drugs, and diagnostic tools to better diagnose, prevent, and treat infectious diseases.
What's New
Latest News Releases
- NIH Awards $12 Million for Antiviral Therapeutic Development
November 21, 2022 - Clinical Trial Evaluating Monkeypox Vaccine Begins
September 8, 2022
NIAID Now Blog
- Candida auris—a mysterious and tenacious enemy
September 23, 2022 - Cornell Professor—Environment Drives Mosquito-borne Diseases
August 19, 2022
Organization
Also see a list of DMID Contacts.
Funding Opportunities
NIAID and NIH offer a number of funding opportunities, including grants and contracts to conduct basic research, preclinical development, or clinical evaluation.
Potential Funding Opportunities:
- Concepts: Potential Opportunities for DMID
Resources for Researchers
DMID supports a comprehensive set of resources for researchers. Their purpose is to facilitate the preclinical and clinical research needed to translate the ideas generated through basic research into safe and effective drugs, vaccines, and diagnostics to control and prevent infectious diseases.